Fahar Merchant - Net Worth and Insider Trading

Fahar Merchant Net Worth

The estimated net worth of Fahar Merchant is at least $13 Million dollars as of 2024-11-08. Fahar Merchant is the 10% Security Holder, Director, Senior Officer of Medicenna Therapeutics Corp and owns about 5,351,400 shares of Medicenna Therapeutics Corp (TSX:MDNA) stock worth over $13 Million. Details can be seen in Fahar Merchant's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fahar Merchant has not made any transactions after 2023-02-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Fahar Merchant

To

Fahar Merchant Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fahar Merchant owns 1 companies in total, including Medicenna Therapeutics Corp (TSX:MDNA) .

Click here to see the complete history of Fahar Merchant’s form 4 insider trades.

Insider Ownership Summary of Fahar Merchant

Ticker Comapny Transaction Date Type of Owner
TSX:MDNA Medicenna Therapeutics Corp 2023-02-21 10% Security Holder & Director & Senior Officer

Fahar Merchant Latest Holdings Summary

Fahar Merchant currently owns a total of 1 stock. Fahar Merchant owns 5,351,400 shares of Medicenna Therapeutics Corp (TSX:MDNA) as of February 21, 2023, with a value of $13 Million.

Latest Holdings of Fahar Merchant

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:MDNA Medicenna Therapeutics Corp 2023-02-21 5,351,400 2.47 13,217,958

Holding Weightings of Fahar Merchant


Fahar Merchant Form 4 Trading Tracker

According to the SEC Form 4 filings, Fahar Merchant has made a total of 9 transactions in Medicenna Therapeutics Corp (TSX:MDNA) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Medicenna Therapeutics Corp is the acquisition of 30,000 shares on February 21, 2023, which cost Fahar Merchant around $27,600.

Insider Trading History of Fahar Merchant

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fahar Merchant Trading Performance

GuruFocus tracks the stock performance after each of Fahar Merchant's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fahar Merchant is -10.12%. GuruFocus also compares Fahar Merchant's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fahar Merchant within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fahar Merchant's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fahar Merchant

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.39 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Fahar Merchant Ownership Network

Ownership Network List of Fahar Merchant

No Data

Ownership Network Relation of Fahar Merchant

Insider Network Chart

Fahar Merchant Owned Company Details

What does Medicenna Therapeutics Corp do?

Who are the key executives at Medicenna Therapeutics Corp?

Fahar Merchant is the 10% Security Holder & Director & Senior Officer of Medicenna Therapeutics Corp. Other key executives at Medicenna Therapeutics Corp include and Senior Officer Elizabeth Williams .

Medicenna Therapeutics Corp (TSX:MDNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Medicenna Therapeutics Corp (TSX:MDNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medicenna Therapeutics Corp (TSX:MDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Medicenna Therapeutics Corp (TSX:MDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Medicenna Therapeutics Corp Insider Transactions

No Available Data

Fahar Merchant Mailing Address

Above is the net worth, insider trading, and ownership report for Fahar Merchant. Currently GuruFocus does not have mailing address information for Fahar Merchant.